Skin and wound infections: An overview

American Family Physician

Volumn 57, Issue 10, 1998, Pages 2424-2432

  O'Dell, Michael L ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; BACITRACIN; CEFALEXIN; CEFTAZIDIME; CEFTAZIDIME ARGININE; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; ERYTHROMYCIN; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; NAFCILLIN; NEOSPORIN; POLYSPORIN; PSEUDOMONIC ACID; RABIES VACCINE; TERBINAFINE; TETANUS TOXOID;

ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; BITE; CORYNEBACTERIUM; DERMATOMYCOSIS; ECTHYMA; ERYSIPELAS; FOLLICULITIS; HUMAN; IMPETIGO; INTRAVENOUS DRUG ADMINISTRATION; KERATOLYSIS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; RABIES; REVIEW; SKIN INFECTION; SPOROTRICHOSIS; STAPHYLOCOCCUS; STREPTOCOCCUS; TETANUS PROPHYLAXIS; TINEA CAPITIS; TINEA CRURIS; TINEA PEDIS; TOPICAL DRUG ADMINISTRATION; WART VIRUS; WOUND INFECTION;

HUMANS; SKIN DISEASES, INFECTIOUS; WOUND INFECTION;

EID: 0032524076     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Dagan R, Bar-David Y. Double-blind study comparing erythromydn and mupirocin for treatment of impetigo in children; implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992;36:287-90.
2. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococccal nasal colonization and skin infection. Arch Intern Med 1996;156:1109-12.
3. Misko ML, Terracina JR, Diven DG. The frequency of erythromycin-resistant Staphylococcus aureus in impetiginized dermatoses. Pediatr Dermatol 1995;12:12-5.
4. Trubo R, Bisno AL, Hacker SM, Roaten SP Jr. Today's strategies for bacterial skin infections. Patient Care 1997;31(6):78-94.
5. Trueb RM, Gloor M, Wuthrich B. Recurrent Pseudomonas folliculitis. Pediatr Dermatol 1994;11:35-8.
6. Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 1995;133:254-8.
7. Rubin RJ, Chinn BT. Perianal hidradenitis suppurativa. Surg Clin North Am 1994;74:1317-25.
8. Chartier C, Grosshans E. Erysipelas: an update. Int J Dermatol 1996;35:779-81.
9. Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serologic aspects. Clin Infect Dis 1996;23:1091-8.
10. Cohen BA, Pinkowish MD. Are warts and children inseparable? Patient Care 1997;31(7):163-84.
11. Franco EL. Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am 1996;23:597-623.
12. Beutner KR. Human papillomavirus infection of the vulva. Semin Dermatol 1996;15:2-7.
13. Sterling J. Treating the troublesome wart. Practitioner 1995;239:44-7.
14. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee, American Academy of Dermatology. J Am Acad Dermatol 1996;34(2 Pt 1):282-6.
15. Kovacs SO, Hruza LL, Superficial fungal infections. Getting rid of lesions that don't go away. Postgrad Med 1995;98(6):61-2,68-9,73-5.
16. Elewski B. Tinea capitis. Dermatol Clin 1996;14:23-31.
17. Howard R, Frieden IJ. Tinea capitis: new perspectives on an old disease. Semin Dermatol 1995;14:2-8.
18. Sabota J, Brodell R, Rutecki GW, Hoppes WL. Severe tinea barbae due to Trichophyton verrucosum infection in dairy farmers. Clin Infect Dis 1996;23:1308-10.
19. Leyden JL. Tinea pedis pathophysiology and treatment. J Am Acad Dermatol 1994;31(3 Pt 2):S31-3.
20. Masri-Fridling GD. Dermatophytosis of the feet. Dermatol Clin 1996;14:33-40.
21. Zaias N, Glick B, Rebell G. Diagnosing and treating onychomycosis. J Fam Pract 1996;42:513-8.
22. Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al. Fungal nail disease: a guide to good practice (report of the Working Group of the British Society for Medical Mycology). BMJ 1995;311:1277-81.
23. Gupta AK, Scher RK, de Doncker P, Sauder DN, Shear NH. Onychomycosis. New therapies for an old disease. West J Med 1996;165:349-51.
24. Hay RJ. Yeast infections. Dermatol Clin 1996;14:113-24.
25. Tobin MJ. Vulvovaginal candidiasis: topical vs. oral therapy. Am Fam Physician 1995;51:1715-20, 1723-4.
26. Desai PC, Johnson BA. Oral fluconazole for vaginal candidiasis. Am Fam Physician 1996;54:1337-40, 1345-6.
27. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for superficial mycotic infections of the skin: pityriasis (tinea) versicolor. Guidelines/Outcomes Committee, American Academy of Dermatology. J Am Acad Dermatol 1996;34(2 Pt 1):287-9.
28. Savin R. Diagnosis and treatment of tinea versicolor. J Fam Pract 1996;43:127-32.